Table 2.
Medication use prior to hospitalization
| Cases first admission | Cases recurrent admission | Controls | |
|---|---|---|---|
| Cardiovascular drugs | |||
| Digoxin | 49 (17.2) | 104 (42.4) | 144 (13.7) |
| Loop diuretics | 106 (37.2) | 180 (73.5) | 235 (22.3) |
| Spironoloactone | 13 (4.6) | 66 (26.9) | 46 (4.4) |
| ACE inhibitors | 113 (39.6) | 141 (57.5) | 311 (29.5) |
| Angiotensin II antagonists | 53 (18.6) | 51 (20.8) | 201 (19.1) |
| Beta adrenoceptor blocking agents | 94 (33.0) | 99 (40.4) | 255 (24.2) |
| Nitrates | 69 (24.2) | 98 (40.0) | 191 (18.1) |
| Vasodilators | 19 (6.7) | 24 (9.8) | 46 (4.4) |
| Thiazide diuretics | 37 (13.0) | 19 (7.8) | 138 (13.1) |
| Anti-arrhythmics | 15 (5.3) | 33 (13.5) | 22 (2.1) |
| Alpha adrenoceptor blocking agents | 21 (7.4) | 15 (6.1) | 42 (4.0) |
| Calcium channel blockers | 54 (18.9) | 46 (18.8) | 226 (21.4) |
| Aspirin | 132 (46.3) | 125 (51.0) | 455 (43.2) |
| Antiplatelet drugs excl. aspirin | 17 (6.0) | 18 (7.3) | 89 (8.4) |
| Statins | 94 (34.0) | 63 (25.7) | 275 (26.1) |
| Warfarin | 41 (14.4) | 58 (23.7) | 83 (7.9) |
| Other drugs | |||
| Ulcer-healing drugs | 97 (34.0) | 106 (43.3) | 408 (38.7) |
| Antidiabetic drugs | 70 (24.6) | 58 (23.7) | 150 (14.2) |
| Respiratory drugs | 113 (39.6) | 102 (41.6) | 593 (56.3) |
| CNS drugs | 90 (31.6) | 78 (31.8) | 431 (40.9) |
CNS, central nervous system; Statins, HMG CoA reductase inhibitors.